Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants
Clinical trial NCT01861730 · COMPLETED
Trial details
- NCT number
- NCT01861730
- Sponsor
- Aeras
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2017-12-22
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.